bupropion hydrochloride

Generic: bupropion hydrochloride

Labeler: bryant ranch prepack
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name bupropion hydrochloride
Generic Name bupropion hydrochloride
Labeler bryant ranch prepack
Dosage Form TABLET, EXTENDED RELEASE
Routes
ORAL
Active Ingredients

bupropion hydrochloride 150 mg/1

Manufacturer
Bryant Ranch Prepack

Identifiers & Regulatory

Product NDC 71335-2469
Product ID 71335-2469_0c3952f8-d149-4812-bec9-ecf841fe1950
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA215568
Listing Expiration 2026-12-31
Marketing Start 2022-12-15

Pharmacologic Class

Classes
aminoketone [epc] dopamine uptake inhibitors [moa] increased dopamine activity [pe] increased norepinephrine activity [pe] norepinephrine uptake inhibitors [moa]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 713352469
Hyphenated Format 71335-2469

Supplemental Identifiers

RxCUI
993541
UNII
ZG7E5POY8O

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name bupropion hydrochloride (source: ndc)
Generic Name bupropion hydrochloride (source: ndc)
Application Number ANDA215568 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 150 mg/1
source: ndc
Packaging
  • 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-2469-1)
  • 60 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-2469-2)
  • 90 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-2469-3)
  • 120 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-2469-4)
  • 14 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-2469-5)
source: ndc

Packages (5)

Ingredients (1)

bupropion hydrochloride (150 mg/1)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "0c3952f8-d149-4812-bec9-ecf841fe1950", "openfda": {"unii": ["ZG7E5POY8O"], "rxcui": ["993541"], "spl_set_id": ["af5b1cc8-f078-4a7b-b64a-4cb2de1e5721"], "manufacturer_name": ["Bryant Ranch Prepack"]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-2469-1)", "package_ndc": "71335-2469-1", "marketing_start_date": "20241112"}, {"sample": false, "description": "60 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-2469-2)", "package_ndc": "71335-2469-2", "marketing_start_date": "20241112"}, {"sample": false, "description": "90 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-2469-3)", "package_ndc": "71335-2469-3", "marketing_start_date": "20241112"}, {"sample": false, "description": "120 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-2469-4)", "package_ndc": "71335-2469-4", "marketing_start_date": "20241112"}, {"sample": false, "description": "14 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-2469-5)", "package_ndc": "71335-2469-5", "marketing_start_date": "20241112"}], "brand_name": "Bupropion hydrochloride", "product_id": "71335-2469_0c3952f8-d149-4812-bec9-ecf841fe1950", "dosage_form": "TABLET, EXTENDED RELEASE", "pharm_class": ["Aminoketone [EPC]", "Dopamine Uptake Inhibitors [MoA]", "Increased Dopamine Activity [PE]", "Increased Norepinephrine Activity [PE]", "Norepinephrine Uptake Inhibitors [MoA]"], "product_ndc": "71335-2469", "generic_name": "Bupropion hydrochloride", "labeler_name": "Bryant Ranch Prepack", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Bupropion hydrochloride", "active_ingredients": [{"name": "BUPROPION HYDROCHLORIDE", "strength": "150 mg/1"}], "application_number": "ANDA215568", "marketing_category": "ANDA", "marketing_start_date": "20221215", "listing_expiration_date": "20261231"}